Screener
BioMarin Pharmaceuticals BMRN Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from BioMarin Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: BioMarin Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001048477-26-000016
FAQ
- What is BioMarin Pharmaceuticals's free cash flow margin?
- BioMarin Pharmaceuticals (BMRN) reported free cash flow margin of 21.7% in Q2 2026.
- How has BioMarin Pharmaceuticals's free cash flow margin changed year-over-year?
- BioMarin Pharmaceuticals's free cash flow margin decreased by 4.5% year-over-year, from 22.7% to 21.7%.
- What is the long-term trend for BioMarin Pharmaceuticals's free cash flow margin?
- Over 3 years (2020 to 2025), BioMarin Pharmaceuticals's free cash flow margin has grown at a 139.4% compound annual growth rate (CAGR), from -1.6% to 22.5%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about BioMarin Pharmaceuticals's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude